secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2022-02-24T23:59:59+00:00
Accession:  0001562762-22-000054
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed Q4 2021 adj EPS $5.25, up 2.3%; VITAS revenue down 4.8%; issues mixed 2022 guidance
--------------------------------------------------------------------------------

- Consolidated Q4 revenue $541M (+1.4%); GAAP diluted EPS $4.81; adjusted diluted EPS $5.25 (+2.3%).
- VITAS net revenue $316M (-4.8%), ADC 17,935 (-4.2%), admissions down 9.5%; adjusted EBITDA margin 21.7% (-179 bps).
- Roto-Rooter revenue $225M (+11.8%); adjusted EBITDA $62.2M (+14.2%); margin 27.7% (+58 bps).
- 2022 guidance: adjusted EPS $19.10-$19.50 (vs 2021 $19.33); VITAS revenue down 1.5-2.5%; Roto-Rooter revenue growth 8-9.5%.
- Q4 share repurchases: 495,529 shares for $246M; $202M remaining authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000156276222000054/0001562762-22-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000156276222000054/che-20220224x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-22-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer